The Vaccine Manufacturing and Innovation Centre (VMIC) requires an eQMS IT system, for its quality assurance function. The contract term is 3 years with an option to extend for a further 2 x 12-month periods.

The Vaccine Manufacturing and Innovation Centre (VMIC) is being established to promote, develop and accelerate the growth of the UK vaccine industry. This will be achieved through collaboration with the academic sector and SMEs, which are rich in new vaccine technologies, where VMIC provides expertise in process development and manufacturing in the form of expert staff and a state-of-the-art manufacturing facility. VMIC will bridge the gap between research and expertise in development and manufacturing so that new vaccine products can enter clinical development, which is a value driver in terms of attracting funding for further development, partnering with the pharmaceutical industry for development to launch and contract manufacturing.

VMIC will also enhance UK preparedness and response capabilities for producing vaccines against emerging infectious diseases by allowing the UK government to use the facility and staff during an outbreak identified as a public health emergency of international concern. VMIC is a partner in the programme to manufacture the Oxford Covid-19 vaccine.

VMIC UK has procured an eQMS IT system, for its quality assurance function, which meets the requirements as set out in the tender documents. This system is within scope for regulatory compliance as it forms part of the VMIC GMP manufacturing capability. As part of the supply of this system, the supplier is expected to support VMIC’s validation of the system. The delivery of the system also includes other elements as set out in the tender documents.

The contract term required is 3 years with an option to extend for a further 2 x 12-month periods.